Evidence of phenolic compounds as modulators of ChREBP and NRF2 in type 2 diabetes: a review of their potential for drug development
24/11/2022
Guy Cohen
Proença, C., Lobo, M.C., Rufino, A.T. et al. Evidence of phenolic compounds as modulators of ChREBP and NRF2 in type 2 diabetes: a review of their potential for drug development. Phytochem Rev (2025). https://doi.org/10.1007/s11101-025-10075-z
